About Biotrove
Biotrove is a company based in Woburn (United States) founded in 1997 was acquired by Life Technologies in November 2009. Biotrove has raised $39.26 million across 8 funding rounds from investors including NIH, HHS and Fletcher Spaght. Biotrove operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
- Headquarter Woburn, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biotrove, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$39.26 M (USD)
in 8 rounds
-
Latest Funding Round
$13.31 M (USD), Series B
Jun 03, 2009
-
Investors
NIH
& 6 more
-
Employee Count
Not available
-
Acquired by
Life Technologies
(Nov 10, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biotrove
Biotrove has successfully raised a total of $39.26M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $13.31 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biotrove
Biotrove has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Fletcher Spaght.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Support is provided for life science ventures by BioFrontier.
|
Locked | Locked | Locked |
Investor details for Biotrove
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biotrove
Investment portfolio details for Biotrove
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biotrove
Detailed financials for Biotrove
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotrove Comparisons
Peer comparison for Biotrove
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biotrove
Biotrove operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| Locked | Locked | Locked |
Provider of genome analysis solutions to researchers and clinicians
|
Detailed competitors of Biotrove
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotrove
Complete news archive for Biotrove
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biotrove
Biotrove was founded in 1997 and raised its 1st funding round 5 years after it was founded.
Biotrove is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Biotrove is a funded company, having raised a total of $39.26M across 8 funding rounds to date.
Biotrove was founded in 1997 and is located in Woburn, United States. Micro- and nano-scale technology platforms are developed for applications in life sciences and drug discovery research. Operations focus on enabling high-throughput assays, with the flagship Open Array platform supporting up to 3000 simultaneous qPCR tests for genotyping and gene expression analysis in research settings.
Biotrove has 7 investors. Key investors include NIH, HHS, Fletcher Spaght, Life Technologies, and Catalyst Health Ventures.